期刊文献+

散发型高IgM综合征CD_(40)配体基因突变检测 被引量:4

Characterization of a novel mutation in the CD40 ligand gene in a patient with sporadic hyper IgM syndrome
原文传递
导出
摘要 目的揭示1例散发型高IgM综合征(HIM)患儿发病机制及其遗传类型,从而为其今后可能的基因治疗打下基础。方法用夹心酶联免疫吸附试验(ELISA)法检测患儿外周血单个核细胞分泌免疫球蛋白的能力;用单克隆抗体染色检测CD40配体(CD40L)表达情况;聚合酶链反应(PCR)产物直接序列分析检测患儿CD40L开放阅读框架基因突变。结果此例HIM患儿B细胞体外刺激可产生IgG,T细胞表面CD40L染色阴性,序列分析发现654657位碱基缺失。结论患儿B细胞可能具有正常Ig分泌功能,Ig同种型转换障碍是由于其T细胞CD40L基因缺失。 Objective To identify the inherited mode of sporadic hyper IgM syndrome (HIM) in a Chinese patient and to lay a foundation for the future gene therapy for the patients. Methods IgG, IgA, and IgM secretion by peripheral blood mononuclear cells in vitro was examined with enzyme linked immunosorbent assay. Ligand (CD 40 L) expression on activated T cells was detected by staining with CD 40 LmAb. Direct sequencing was used to identify the mutations on CD 40 L cDNA open reading frame. Results Costimulation of B cells in vitro from the sporadic HIM patient resulted in IgG production. CD 40 L expression was completely negative. Sequencing analysis showed a 4 base deletion (AGAT) at 654 657 in the patient′s CD 40 L open reading frame. Conclusion Failure of B cells to undergo immunoglobulin isotype switch in this case is a result of mutation on the CD 40 L gene in the activated T cells and B cells may have the ability to secrete IgG. This is the first case of HIGM with X linked inheritance diagnosed at a molecular level in China.
出处 《中华儿科杂志》 CAS CSCD 北大核心 1998年第6期328-330,共3页 Chinese Journal of Pediatrics
基金 国家自然科学基金
关键词 CD40配体 基因突变 高IGM综合征 儿童 IgM Hypergammaglobulinemia Antigens, CD 40 Ligards
  • 相关文献

同被引文献39

  • 1应大明 王晓川 杨锡强 等.原发性免疫缺陷病的协作网和登记工作[J].中华儿科杂志,1999,37:328-329.
  • 2Fischer A. Human primary immunodeficiency diseases: a perspective[J]. Nature Immunol, 2004, 5: 23-30.
  • 3Tsukada S, Saffran DC, Rawlings DJ, et al. Deficient expression of a 15 cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia[J]. Cell, 1993, 72:279-290.
  • 4Conley ME, Mathias D, Treadaway J, et al. Mutations in btk in patients with presumed X-linked agammaglobulinemia [J]. Am J Hum Genet, 1998, 62: 1034.
  • 5Granados EL, Porpiglia AS, Hogan MB, et al. Clinical and molecular analysis of patients with defects in μ heavy chain gene[J]. J Clin Invest, 2002, 110:1029.
  • 6Yel L, Minegishi Y, Coustan-Smith E, et al. Mutations in the mu heavy-chain gene in patients with agamrnaglobulinemia[J]. N Engl J Med, 1996,335:1486-1493.
  • 7Conley ME. Genes required for B cell development[J]. J Clin Invest, 2003, 112: 1636.
  • 8Minegishi Y, Coustan Smith E, Wang YH, et al. Mutations in the human lambda 5/14.1 gene result in B cell deficiency and agammaglobulinemia[J], J Exp Med, 1998, 187: 71- 77.
  • 9Minegishi Y, Coustan-Smith E, Rapalus L, et al. Mutations in Igα (CD79a) result in a complete block in B cell development[J]. J Clin Invest, 1999,104:1115-1121.
  • 10Pappu R, Cheng AM, Li B, et al. Requirement for B cell lin ker protein (BLNK) in B cell development [J]. Science, 1999,286:1949.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部